What is Advanced BioNutrition?
Founded in 2001 and headquartered in Columbia, Maryland, Advanced BioNutrition (ABN) operates as a premier technology provider specializing in environmentally sustainable, science-based delivery solutions. The company serves a diverse array of sectors, including Human Health & Nutrition, Agriculture, and Biopharma. By leveraging a multidisciplinary team of biologists, chemists, and engineers, ABN addresses complex formulation challenges, enabling partners to enhance the performance and value of sensitive bioactives. ABN's core competencies lie in its proprietary stabilization platforms, which are critical for maintaining the efficacy of ingredients across various industrial applications. As a leader in the bio-nutrition space, the firm continues to bridge the gap between laboratory research and commercial-scale product development.
How much funding has Advanced BioNutrition raised?
Advanced BioNutrition has raised a total of $11.4M across 5 funding rounds:
Unspecified
$1M
Series A
$2.5M
Series B
$7.5M
Debt
$150K
Debt
$280K
Unspecified (2002): $1M with participation from Sherbrooke Capital
Series A (2003): $2.5M led by Sherbrooke Capital
Series B (2005): $7.5M, investors not publicly disclosed
Debt (2020): $150K featuring PPP
Debt (2021): $280K backed by PPP
Key Investors in Advanced BioNutrition
Sherbrooke Capital
Sherbrooke Capital is a specialized investment firm focused on providing growth capital to emerging companies within the Healthy, Active, and Sustainable Living sectors.
PPP
Public-Private Partnership
What's next for Advanced BioNutrition?
With the successful completion of its recent financing round, Advanced BioNutrition is well-positioned to accelerate its research and development initiatives. The company is expected to focus on expanding its footprint within the global biopharma and agricultural markets, where demand for high-performance, sustainable delivery systems is rising. By utilizing this capital to refine its proprietary technologies, ABN aims to solve increasingly complex formulation hurdles for its enterprise-level clients. Future strategic efforts will likely prioritize the commercialization of new bioactive stabilization methods, further cementing the company's role as an essential partner in the global supply chain for health and nutrition products.
See full Advanced BioNutrition company page
